Logo image of MNDR

MOBILE-HEALTH NETWORK SOLUTI (MNDR) Stock Analyst Earnings Estimates

NASDAQ:MNDR - Nasdaq - KYG622641176 - Common Stock - Currency: USD

1.03  -0.03 (-2.82%)

After market: 1.0207 -0.01 (-0.9%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026
Revenue
YoY % growth
MNDR revenue by date.MNDR revenue by date.
6.989M
170.55%
7.875M
12.68%
13.969M
77.38%
26.391B
188,832.24%
46.565B
76.44%
EBITDA
YoY % growth
MNDR ebitda by date.MNDR ebitda by date.
280.8K
146.98%
-3.194M
-1,237.43%
-15.555M
-387.01%
-1.357B
-8,624.38%
889.3M
165.53%
EBIT
YoY % growth
MNDR ebit by date.MNDR ebit by date.
193.7K
130.29%
-3.289M
-1,797.83%
-15.704M
-377.50%
-1.455B
-9,165.09%
790.36M
154.32%
Operating Margin
MNDR operating margin by date.MNDR operating margin by date.
2.77%-41.76%-112.42%-5.51%1.70%
EPS
YoY % growth
MNDR eps by date.MNDR eps by date.
N/AN/AN/A-0.04
96.15%
0.02
150.00%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
MNDR Yearly EPS VS EstimatesMNDR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
13.969M
77.38%
%
Q2 2024
Q2Q % growth
6.644M
122.33%
%
MNDR Yearly Revenue VS EstimatesMNDR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 10B 20B 30B 40B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%